Immuno-based botulinum toxin serotype A activity assays

Details for Australian Patent Application No. 2009223161 (hide)

Owner Allergan, Inc.

Inventors Hodges, D. Dianne; Fernandez-Salas, Ester; Wang, Joanne; Garay, Patton E.; Wong, Lina S.; Aoki, Kei Roger

Agent Davies Collison Cave

Pub. Number AU-A-2009223161

PCT Pub. Number WO2009/114748

Priority 61/036,723 14.03.08 US

Filing date 13 March 2009

Wipo publication date 17 September 2009

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

7 October 2010 PCT application entered the National Phase

  PCT publication WO2009/114748 Priority application(s): WO2009/114748

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009223162-Carrageenan modified by ion-exchange process

2009223158-Formulations of vitamin K analogs for topical use